Cargando…
A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation
BACKGROUND: Familial hypocalciuric hypercalcemia (FHH) is a rare autosomal dominant disease, which requires differential diagnosis from relatively common primary hyperparathyroidism (PHPT) in order to avoid unnecessary surgery. CASE PRESENTATION: A 16-year-old female had been followed by the departm...
Autores principales: | Sumida, Akira, Iizuka, Katsumi, Kato, Takehiro, Liu, Yanyan, Kubota, Sodai, Kubota-Okamoto, Saki, Sakurai, Teruaki, Imaizumi, Toshinori, Takahashi, Yoshihiro, Mizuno, Masami, Takao, Ken, Hirota, Takuo, Suwa, Tetsuya, Horikawa, Yukio, Yamamoto, Mayumi, Seino, Yusuke, Suzuki, Atsushi, Yabe, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214973/ https://www.ncbi.nlm.nih.gov/pubmed/35733207 http://dx.doi.org/10.1186/s12902-022-01077-5 |
Ejemplares similares
-
Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment
por: Tsukada, Daichi, et al.
Publicado: (2022) -
Identification of a novel large CASR deletion in a patient with familial hypocalciuric hypercalcemia
por: García-Castaño, Alejandro, et al.
Publicado: (2018) -
A Novel Missense CASR Gene Sequence Variation Resulting in Familial Hypocalciuric Hypercalcemia
por: Bletsis, Panagiotis, et al.
Publicado: (2022) -
A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia
por: Tonyushkina, Ksenia N, et al.
Publicado: (2012) -
Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies
por: Makita, Noriko, et al.
Publicado: (2022)